News | March 15, 2023
Philips and Gibraltar Health Authority announce 16-year strategic partnership
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
The business serves the healthcare and laboratory sectors on the west coast of the United States.
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
There is a fast resurgence in the transplant activities post COVID
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
Subscribe To Our Newsletter & Stay Updated
